€25 million investment helps HTBA produce all active forms of B12

€25 million investment helps HTBA produce all active forms of B12

HealthTech BioActives (HTBA) has completed a €25 million investment project to modernise its research, development and manufacturing centre in Murcia, Spain. The initiative included the construction of a new state-of-the-art production plant, which was officially inaugurated on Tuesday 28 January, making HTBA the only company in Europe capable of producing all active forms of vitamin…


HealthTech BioActives (HTBA) has completed a €25 million investment project to modernise its research, development and manufacturing centre in Murcia, Spain.

The initiative included the construction of a new state-of-the-art production plant, which was officially inaugurated on Tuesday 28 January, making HTBA the only company in Europe capable of producing all active forms of vitamin B12, reinforcing its status as a leader in the industry.

The multi-million-euro project aimed to introduce advanced manufacturing processes and sustainability measures to strengthen HTBA’s position as a prominent player in the sector and reduce its environmental footprint.

The investment also involved the modernisation of the company’s existing citrus flavonoid production plant, enabling further development of HTBA’s patented manufacturing process for a specific type of flavonoid, diosmin – an ingredient that can help promote blood circulation and address vascular discomfort. This new production process replaces artificial solvents with water. As a result, HTBA is now the only company in the world capable of manufacturing diosmin without the use of artificial solvents.

“Our origins in citrus flavonoids and vitamin B12 date back more than 45 years and this innovation project marks a huge milestone for HTBA, demonstrating our unwavering dedication to producing high-quality, environmentally responsible products on a global scale,” comments Alexandre Valls-Coma, chief executive officer of HTBA. “Through this significant investment, we’re not only reinforcing our global leadership in the production of active forms of vitamin B12 and citrus flavonoids, but we’re also furthering our commitment to upholding the highest standards in sustainability and innovation.”

In line with the company’s ongoing commitment to sustainability, the new and upgraded facilities harness advanced technology and automation systems that support the use of renewable energy and optimise resource consumption. Overall, the investment has enabled 98% of waste generated to be recovered, revalued or recycled.

Related content


Stories for you


  • Muirhead adds certification muscle through acquisition

    Muirhead adds certification muscle through acquisition

    Cabin interiors are increasingly being won through vertical integration strategies. Muirhead’s parent Scottish Leather Group has acquired Aerotech Systems, bringing UK CAA Part 21G production approval into the group as it broadens its aviation seating offer.


  • IntelliAM deepens Scottish engineering footprint with acquisition

    IntelliAM deepens Scottish engineering footprint with acquisition

    Industrial AI is moving closer to plant-level service delivery models. IntelliAM’s acquisition of RBM Lubrications adds field engineering capability in Scotland and tightens the link between condition monitoring, lubrication, and machine-learning-led asset management.